Mohegan Lake, NY, United States of America

Richat Abbas




Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 53(Granted Patents)


Location History:

  • Audubon, PA (US) (2008)
  • Mohegan Lake, NY (US) (2013)

Company Filing History:


Years Active: 2008-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richat Abbas: Innovator in Diabetes Treatment

Introduction

Richat Abbas is an accomplished inventor based in Mohegan Lake, NY, known for his significant contributions to the field of pharmaceutical innovations. With two patents to his name, Richat has focused on developing formulations that aim to improve the treatment of diabetes and enhance drug delivery mechanisms.

Latest Patents

Richat Abbas has been granted patents for two notable inventions. The first patent is for “Formulations for oral administration of cromolyn sodium.” This invention includes an oral dosage form that comprises cromolyn sodium, along with an acylated amino acid delivery agent, providing a more effective method for administering this compound.

The second patent is dedicated to “Oral insulin therapy,” which involves pharmaceutical dosage forms for the oral administration of insulin to treat diabetes. This invention includes a delivery agent that facilitates the transport of insulin into the bloodstream while reducing the risk of vascular diseases associated with repetitive insulin use. Additionally, the patent outlines a method for minimizing health risks linked with chronic insulin dosing by ensuring optimal absorption from the gastrointestinal tract when administered with a suitable delivery agent.

Career Highlights

Richat Abbas is associated with Emisphere Technologies, Inc., where his innovative work has advanced the field of diabetes treatment. His expertise in pharmaceutical formulations has played a crucial role in the development of new therapies that aim to improve patient outcomes.

Collaborations

Throughout his career, Richat has collaborated with esteemed colleagues, including Ehud Arbit and Michael M Goldberg. This collaborative approach fosters an environment of innovation and knowledge sharing, further enhancing the effectiveness of his research and inventions.

Conclusion

Richat Abbas stands out as an inventive force in the pharmaceutical industry with his focus on improving diabetes treatment methodologies. His patents reflect a commitment to innovation and a passion for addressing significant healthcare challenges, contributing meaningfully to advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…